bottom line underweight rate quest reflect
view structur challeng clinic lab industri could mute
upsid opportun share gain dgx report
result guidanc challeng view
beat driven strong volum growth pama headwind
continu report organ growth ahead
model street consensu adj oper
margin also higher assumpt
street consensu price headwind
includ pama impact expect similar pama
headwind continu
deal activ pick memori hermann
tennesse deal provid upsid opportun volum growth
advanc
transact build capabl
model updat increas estim
 note herein maintain
underweight rate target price
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
exclud amort intang restructur non-recur item
exclud amort intang restructur non-recur item
exclud amort intang restructur non-recur item
exclud amort intang restructur non-recur item
compani data secur llc estim reuter
period end oper expens expens incom expens earn equiti method incom non-control alloc particip incom ep dilut share share growth sale margin ex restat cash flowoper cash cash began report adj ep ex amort begin prior period includ amort compani adjust present reconcil provid quarter disregard ep present period earlier sinc adequ exclud atax effect amort onward exclud line-item amort conform adj ep revenu growth percentag base restat revenu number new uncollect balanc revenu recognit rulesourc well fargo secur llc estim compani report incorpor
price target nc
price target reflect enterpris valu use project level debt cash
ebitda ex option multipl consist median lab
healthcar provid comp group believ appropri balanc opportun associ
expand manag care access off-set structur challeng upsid risk underweight rate
includ limit follow factor first compani achiev
faster share gain model could increment upsid forecast valuat
expect secondli greater execut cost effici program off-set price pressur
materi could underestim margin trajectori upsid risk includ meaning
 upsid favor resolut pama data collect process result unforeseen price relief
potenti industri particip find asset attract
underweight rate quest diagnost reflect view structur challeng
clinic lab industri could mute upsid opportun share gain
base madison nj quest diagnost largest revenu clinic refer laboratori
compani compani conduct wide rang clinic diagnost test routin esoter
primarili
